Boston Children's Hospital
childrenshospital.orgTotal trials
597
Active
176
Phase 3
24
Total enrollment
227,848
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 56 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| low bile acid binding blenderized diet | — | — | — | — | 3 | ||
| high bile acid binding blenderized diet | — | — | — | — | 3 | ||
| Famotidine | — | — | — | — | — | 2 | |
| Ofloxacin otic solution | — | — | — | — | — | 1 | |
| methylprednisolone acetate and lidocaine | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 | |
| Skin Cleanser Combination No.1 | — | — | — | — | — | 1 | |
| Dexmedetomidine (IV) 0.5 mcg/kg | — | — | — | — | — | 1 | |
| Propofol (IV) 2-4 mg/kg | — | — | — | — | — | 1 | |
| Dexmedetomidine (IV) 1 mcg/kg | — | — | — | — | — | 1 | |
| Propofol (IV) 1-2 mg/kg | — | — | — | — | — | 1 | |
| Propofol (IV) Infusion 250 mcg/kg/min | — | — | — | — | — | 1 | |
| Propofol (IV) Infusion 150 mcg/kg/min | — | — | — | — | — | 1 | |
| liquid oxycodone | — | — | — | — | — | 1 | |
| Dupilumab | — | — | — | — | — | 1 | |
| Prucalopride | — | — | — | — | — | 1 | |
| oral oxycodone | — | — | — | — | — | 1 | |
| amino acid based formula | — | — | — | — | — | 1 | |
| Tacrolimus | — | — | — | — | 3 | ||
| Ketamine Hydrochloride | — | — | — | — | — | 2 | |
| Fludarabine | — | — | — | — | 2 | ||
| Mycophenolate mofetil | — | — | — | — | 2 | ||
| Cyclosporine | — | — | — | — | — | 2 | |
| Methotrexate | — | — | — | — | 2 | ||
| Everolimus blinded oral | — | — | — | — | — | 1 | |
| horse anti-thymocyte globulin | — | — | — | — | — | 1 | |
| rabbit anti-thymocyte globulin | — | — | — | — | — | 1 | |
| Cyclophosphamide | — | — | — | — | — | 1 | |
| Gabapentin | — | — | — | — | — | 1 | |
| Oxcarbazepine | — | — | — | — | — | 1 | |
| Everolimus | — | — | — | — | — | 1 | |
| Omalizumab | — | — | — | — | 3 | ||
| Abatacept | — | — | — | — | — | 3 | |
| Interleukin-2 (aldesleukin). | — | — | — | — | — | 1 | |
| Metformin Hydrochloride | — | — | — | — | — | 1 | |
| Everolimus and lonafarnib | — | — | — | — | — | 1 | |
| Valproate | — | — | — | — | — | 1 | |
| alemtuzumab | — | — | — | — | — | 1 | |
| Cyclosporins | — | — | — | — | — | 1 | |
| Indocyanine Green | — | — | — | — | — | 1 |
16 more active programs hidden
Next readouts
- 2023-04-17
- 2024-09
- 2026-05
- 2026-06
- 2026-06
- 2026-08
- 2026-08-01
- 2026-12
- 2026-12
- 2026-12
Top conditions
- Congenital Heart Disease25
- Obesity16
- Asthma16
- Cystic Fibrosis14
- Autism Spectrum Disorder13
- Alcohol Abuse10
- Epilepsy9
- Anesthesia9
Frequently asked questions about Boston Children's Hospital
- How many clinical trials does Boston Children's Hospital have on ClinicalTrials.gov?
- Boston Children's Hospital is listed as the lead sponsor on 597 clinical trials in ClinicalTrials.gov, 176 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Boston Children's Hospital's trials are in Phase 3?
- 24 of Boston Children's Hospital's trials are in Phase 3, spread across 56 active drug programs.
- What therapeutic areas does Boston Children's Hospital focus on?
- Boston Children's Hospital's most-studied conditions on ClinicalTrials.gov are Congenital Heart Disease, Obesity, Asthma, Cystic Fibrosis, Autism Spectrum Disorder.
- When are Boston Children's Hospital's next clinical trial readouts?
- Boston Children's Hospital has 10 upcoming primary-completion readouts tracked here; the soonest is “Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score”, expected around 2023-04-17.